The SLC12A3 gene gives the kidneys instructions for moving salt back into the body, which helps keep fluid levels and minerals such as potassium and magnesium in balance. This gene plays an important role in steady blood pressure and normal muscle and nerve function. If it does not work properly, people may lose too much salt in the urine and develop Gitelman syndrome, which can cause fatigue, muscle cramps, weakness, dizziness, and low potassium or magnesium levels.
What is a gene?
Genes are sections of DNA that hold instructions your cells use to make molecules or manage activities in the body. Some genes carry the directions for producing proteins, which are the functional parts of cells. Others mainly help regulate when certain processes happen, where they take place, and how active they are. In combination, genes affect how the body grows and works, and they can influence how you respond to food, stress, and medicines. For a deeper look at this subject, you can read more in the LearnHub.
Overview
SLC12A3Gene function
What if the gene works
The SLC12A3 gene helps your kidneys reabsorb sodium and chloride from urine. This supports healthy salt balance, affects potassium and magnesium levels, and helps your body regulate fluid balance and blood pressure.
Risk
What if the gene does not work
Certain variants in the SLC12A3 gene can cause Gitelman syndrome, a kidney condition that leads to low potassium and magnesium. Some people have mild fatigue or cramps, while more severe variants can cause earlier, noticeable symptoms and lower blood pressure.
Treatment
What does that mean for your treatment
With a pathogenic or loss-of-function variant in the SLC12A3 gene, treatment usually centers on ongoing magnesium and potassium replacement, often with higher salt intake. Drugs that can help limit potassium loss, such as amiloride, spironolactone, or eplerenone, may be used, while thiazide diuretics are generally avoided because they can worsen the underlying salt loss.
Conditions associated with SLC12A3
Gene function
What if the gene works
In the kidney, the SLC12A3 gene helps your body reclaim salt from the fluid that will become urine. This fine tuning step supports everyday fluid balance and steadier blood pressure. It is most active in a kidney segment that makes final adjustments before urine leaves the body. Understanding how the SLC12A3 gene helps control salt balance in the kidney makes its day to day role easier to picture.
The SLC12A3 gene helps kidney cells move sodium and chloride out of the forming urine and back into the body. This keeps useful salt from being lost and helps set the final salt content of urine.
Because water tends to follow salt, this gene supports healthy body fluid levels. That steady salt and water handling also helps the body maintain normal blood pressure from day to day.
By controlling sodium and chloride movement in the kidney, the SLC12A3 gene helps create the right conditions for fine tuning other minerals. This supports balanced handling of potassium, magnesium, and calcium in urine and blood.
What is a variant?
A genetic variant is a small alteration in the DNA sequence of a gene. These changes are common and help account for normal human diversity, such as differences in appearance, metabolism, or how the body responds to environmental influences. Many variants do not have any noticeable effect and simply represent natural genetic variation. In some cases, though, a variant can change the function of a gene more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the SLC12A3 gene often reduce how well the kidney salt transporter is made, folded, or moved to the cell surface, so it cannot move sodium and chloride normally. Some SLC12A3 gene variants cause only a partial drop in activity, while more disruptive variants can leave little or no working protein. This range can help explain why Gitelman syndrome is milder in some people and more noticeable or appears earlier in others.
How variants are linked to conditions
Pathogenic variants in both copies of the SLC12A3 gene cause Gitelman syndrome, an inherited condition that can explain long-term low potassium and low magnesium. In practice, SLC12A3 gene variants and Gitelman syndrome refer to a confirmed genetic diagnosis, while people carrying one variant usually do not develop the full condition.
A variant is not necessarily a diagnosis
Genetic variants are a routine part of human biology and are common throughout the general population. Most do not have a direct effect on health and simply reflect natural human diversity. For many genes, carrying a variant associated with a condition indicates a possible link rather than a definite diagnosis, especially when several genes and environmental factors are involved. In some situations, however, a single well characterized variant in a specific gene may be enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For SLC12A3, the main risk is inherited: people usually develop this condition only if they receive a changed copy from both parents. Day-to-day symptoms can become more noticeable during vomiting, diarrhea, heavy sweating, or with medicines that lower body salts, such as some water pills or laxatives.
Inheritance of SLC12A3 variants
In SLC12A3-related Gitelman syndrome, inheritance follows an autosomal recessive pattern. This means a person usually develops the condition only when they inherit two SLC12A3 variants, one from each parent. Parents who each carry one variant are typically unaffected carriers, and with each pregnancy they have a 25% chance of having an affected child, a 50% chance of having a child who is also a carrier, and a 25% chance of having a child with no familial variant. This pattern applies equally to sons and daughters.
What does my SLC12A3 result mean for my family?
SLC12A3 results are most often linked to Gitelman syndrome, which usually runs in families in a recessive pattern. For family members, this often means brothers and sisters could also have the condition or be carriers, and parents are usually carriers without symptoms. Other relatives may also carry the gene change, especially on the same side of the family.
Genetic information
Genetic testing
How you find out about variants
Testing for variants in the SLC12A3 gene usually uses a blood sample or cheek swab, which a lab reads to look for changes in the gene's DNA. SLC12A3 genetic testing can confirm or support a diagnosis of Gitelman syndrome and may help clarify whether family members carry the same variant.
When should I consider getting a genetic test?
If blood tests show ongoing low potassium and low magnesium, muscle cramps, tiredness, or a strong family history of Gitelman syndrome, a kidney condition that makes the body lose too much salt, testing the SLC12A3 gene may help confirm the cause. It can also be useful when a close relative has a known SLC12A3 gene change.
A genetic result is only one part of your health story
A genetic result can be informative, but how much it explains varies by the condition and the specific variant involved. Over time, many factors influence how the body works, including lifestyle, environment, age, and medical history. In some conditions, especially those shaped by many genes, genetic information provides context rather than certainty and is most useful when viewed alongside other parts of care. In other situations, a genetic result may offer a clear answer. In areas like medication response, genetic results can also help put individual experiences in context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how your body responds to medicines. Some people break down a drug more slowly or more quickly, while others may be more or less sensitive to its effects. This helps explain why the same treatment can work well for one person, cause more side effects in another, or seem to have less benefit in someone else.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences shape a person’s response to medications. It looks at gene-drug patterns to help explain why the same treatment may work differently from one person to another. For many medicines, genes influence how strongly a drug works or how the body handles it. This information can support more informed and individualized treatment decisions. More detailed information on this topic is available in the LearnHub.
Drugs influenced by the SLC12A3 gene
When should I seek medical advice?
There isn't yet a broadly confirmed role for this gene in guiding medication treatment, so questions about medicine choice, side effects, or new symptoms are best discussed with your doctor. SLC12A3 has been studied in research on how some blood pressure medicines, especially thiazide-type water pills, may work differently in different people, but this is not part of routine prescribing guidance.
History
Doctors first described Gitelman syndrome in 1966 as a distinctive inherited salt balance condition with low potassium and low magnesium. For years, it was recognized by its pattern of lab findings and symptoms rather than by a known genetic cause. Building on this early work, scientists linked the condition to the SLC12A3 gene in the 1990s, which gave families a clearer explanation for why it runs in some relatives. That discovery helped separate Gitelman syndrome from related kidney conditions that can look similar at first. Over time, descriptions became more precise as more SLC12A3 variants were identified in people from different populations. Today, the gene is a well-established part of the diagnostic picture for this condition.